LLIN exposure factor analysis using Poisson regression models constructed with % knockdown at 40 min and % mortality at 24 h as dependent variables, and deployment time/damage type as independent variables, Merida, Mexico (n = 5 replicates for each combination deployment time/damage type)
Strain/net exposure factor . | Knockdown . | . | Mortality . | . |
---|---|---|---|---|
. | Mean (95% CI) . | RR (95% CI) . | Mean (95% CI) . | RR (95% CI) . |
Resistant strain | ||||
Deployment time | ||||
New, nonexposed | 51.9% (40.4–63.3) | 1 | 57.7% (47.2–68.2) | 1 |
6-mo use | 24.6% (18.5–30.7) | 0.47 (0.4–0.5)* | 29.0% (23.8–34.3) | 0.50 (0.5–0.6)& |
12-mo use | 15.3% (11.1–19.5) | 0.29 (0.3–0.3)* | 14.8% (10.5–19.1) | 0.26 (0.2–0.3)* |
Type of damage | ||||
No damage | 43.6% (28.3–58.9) | 1 | 43.3% (27.3–59.2) | 1 |
Lateral | 23.5% (13.9–33.0) | 0.54 (0.5–0.6)* | 23.1% (14.6–31.6) | 0.53 (0.5–0.6)* |
Multiple | 29.4% (16.6–42.2) | 0.67 (0.6–0.8)* | 37% (21.3–52.7) | 0.85 (0.8–0.9)* |
Central | 26% (16.0–35.9) | 0.59 (0.5–0.7)* | 32.1% (23.6–40.5) | 0.74 (0.7–0.8)* |
Susceptible strain | ||||
Deployment time | ||||
New, nonexposed | 81.3% (73.9–88.7) | 1 | 74.6% (65.3–83.9) | 1 |
6-mo use | 78.5% (71.6–85.5) | 0.97 (0.9–1.0) | 72.3% (64.1–80.5) | 0.97 (0.9–1.0) |
12-mo use | 74.3% (62.4–86.4) | 0.91 (0.8–0.9)* | 59% (46.7–71.3) | 0.79 (0.7–0.8)* |
Type of damage | ||||
No damage | 84.2% (76.9–91.4) | 1 | 79.9% (71.6–88.2) | 1 |
Lateral | 70.8% (64.9–76.8) | 0.84 (0.8–0.9)* | 55% (46.3–63.7) | 0.69 (0.6–0.7)* |
Susceptible strain | ||||
Multiple | 85.1% (78.4–91.7) | 1.0 (0.9–1.1) | 74.3% (64.0–84.5) | 0.93 (0.9–1.0) |
Central | 72.1% (55.2–89.1) | 0.86 (0.8–0.9)* | 65.4% (48.7–82.0) | 0.82 (0.7–0.9)* |
Strain/net exposure factor . | Knockdown . | . | Mortality . | . |
---|---|---|---|---|
. | Mean (95% CI) . | RR (95% CI) . | Mean (95% CI) . | RR (95% CI) . |
Resistant strain | ||||
Deployment time | ||||
New, nonexposed | 51.9% (40.4–63.3) | 1 | 57.7% (47.2–68.2) | 1 |
6-mo use | 24.6% (18.5–30.7) | 0.47 (0.4–0.5)* | 29.0% (23.8–34.3) | 0.50 (0.5–0.6)& |
12-mo use | 15.3% (11.1–19.5) | 0.29 (0.3–0.3)* | 14.8% (10.5–19.1) | 0.26 (0.2–0.3)* |
Type of damage | ||||
No damage | 43.6% (28.3–58.9) | 1 | 43.3% (27.3–59.2) | 1 |
Lateral | 23.5% (13.9–33.0) | 0.54 (0.5–0.6)* | 23.1% (14.6–31.6) | 0.53 (0.5–0.6)* |
Multiple | 29.4% (16.6–42.2) | 0.67 (0.6–0.8)* | 37% (21.3–52.7) | 0.85 (0.8–0.9)* |
Central | 26% (16.0–35.9) | 0.59 (0.5–0.7)* | 32.1% (23.6–40.5) | 0.74 (0.7–0.8)* |
Susceptible strain | ||||
Deployment time | ||||
New, nonexposed | 81.3% (73.9–88.7) | 1 | 74.6% (65.3–83.9) | 1 |
6-mo use | 78.5% (71.6–85.5) | 0.97 (0.9–1.0) | 72.3% (64.1–80.5) | 0.97 (0.9–1.0) |
12-mo use | 74.3% (62.4–86.4) | 0.91 (0.8–0.9)* | 59% (46.7–71.3) | 0.79 (0.7–0.8)* |
Type of damage | ||||
No damage | 84.2% (76.9–91.4) | 1 | 79.9% (71.6–88.2) | 1 |
Lateral | 70.8% (64.9–76.8) | 0.84 (0.8–0.9)* | 55% (46.3–63.7) | 0.69 (0.6–0.7)* |
Susceptible strain | ||||
Multiple | 85.1% (78.4–91.7) | 1.0 (0.9–1.1) | 74.3% (64.0–84.5) | 0.93 (0.9–1.0) |
Central | 72.1% (55.2–89.1) | 0.86 (0.8–0.9)* | 65.4% (48.7–82.0) | 0.82 (0.7–0.9)* |
RR = rate ratio, estimated with Poisson regression models. CI = confidence interval.
*P < 0.001.
&P = 0.052.
LLIN exposure factor analysis using Poisson regression models constructed with % knockdown at 40 min and % mortality at 24 h as dependent variables, and deployment time/damage type as independent variables, Merida, Mexico (n = 5 replicates for each combination deployment time/damage type)
Strain/net exposure factor . | Knockdown . | . | Mortality . | . |
---|---|---|---|---|
. | Mean (95% CI) . | RR (95% CI) . | Mean (95% CI) . | RR (95% CI) . |
Resistant strain | ||||
Deployment time | ||||
New, nonexposed | 51.9% (40.4–63.3) | 1 | 57.7% (47.2–68.2) | 1 |
6-mo use | 24.6% (18.5–30.7) | 0.47 (0.4–0.5)* | 29.0% (23.8–34.3) | 0.50 (0.5–0.6)& |
12-mo use | 15.3% (11.1–19.5) | 0.29 (0.3–0.3)* | 14.8% (10.5–19.1) | 0.26 (0.2–0.3)* |
Type of damage | ||||
No damage | 43.6% (28.3–58.9) | 1 | 43.3% (27.3–59.2) | 1 |
Lateral | 23.5% (13.9–33.0) | 0.54 (0.5–0.6)* | 23.1% (14.6–31.6) | 0.53 (0.5–0.6)* |
Multiple | 29.4% (16.6–42.2) | 0.67 (0.6–0.8)* | 37% (21.3–52.7) | 0.85 (0.8–0.9)* |
Central | 26% (16.0–35.9) | 0.59 (0.5–0.7)* | 32.1% (23.6–40.5) | 0.74 (0.7–0.8)* |
Susceptible strain | ||||
Deployment time | ||||
New, nonexposed | 81.3% (73.9–88.7) | 1 | 74.6% (65.3–83.9) | 1 |
6-mo use | 78.5% (71.6–85.5) | 0.97 (0.9–1.0) | 72.3% (64.1–80.5) | 0.97 (0.9–1.0) |
12-mo use | 74.3% (62.4–86.4) | 0.91 (0.8–0.9)* | 59% (46.7–71.3) | 0.79 (0.7–0.8)* |
Type of damage | ||||
No damage | 84.2% (76.9–91.4) | 1 | 79.9% (71.6–88.2) | 1 |
Lateral | 70.8% (64.9–76.8) | 0.84 (0.8–0.9)* | 55% (46.3–63.7) | 0.69 (0.6–0.7)* |
Susceptible strain | ||||
Multiple | 85.1% (78.4–91.7) | 1.0 (0.9–1.1) | 74.3% (64.0–84.5) | 0.93 (0.9–1.0) |
Central | 72.1% (55.2–89.1) | 0.86 (0.8–0.9)* | 65.4% (48.7–82.0) | 0.82 (0.7–0.9)* |
Strain/net exposure factor . | Knockdown . | . | Mortality . | . |
---|---|---|---|---|
. | Mean (95% CI) . | RR (95% CI) . | Mean (95% CI) . | RR (95% CI) . |
Resistant strain | ||||
Deployment time | ||||
New, nonexposed | 51.9% (40.4–63.3) | 1 | 57.7% (47.2–68.2) | 1 |
6-mo use | 24.6% (18.5–30.7) | 0.47 (0.4–0.5)* | 29.0% (23.8–34.3) | 0.50 (0.5–0.6)& |
12-mo use | 15.3% (11.1–19.5) | 0.29 (0.3–0.3)* | 14.8% (10.5–19.1) | 0.26 (0.2–0.3)* |
Type of damage | ||||
No damage | 43.6% (28.3–58.9) | 1 | 43.3% (27.3–59.2) | 1 |
Lateral | 23.5% (13.9–33.0) | 0.54 (0.5–0.6)* | 23.1% (14.6–31.6) | 0.53 (0.5–0.6)* |
Multiple | 29.4% (16.6–42.2) | 0.67 (0.6–0.8)* | 37% (21.3–52.7) | 0.85 (0.8–0.9)* |
Central | 26% (16.0–35.9) | 0.59 (0.5–0.7)* | 32.1% (23.6–40.5) | 0.74 (0.7–0.8)* |
Susceptible strain | ||||
Deployment time | ||||
New, nonexposed | 81.3% (73.9–88.7) | 1 | 74.6% (65.3–83.9) | 1 |
6-mo use | 78.5% (71.6–85.5) | 0.97 (0.9–1.0) | 72.3% (64.1–80.5) | 0.97 (0.9–1.0) |
12-mo use | 74.3% (62.4–86.4) | 0.91 (0.8–0.9)* | 59% (46.7–71.3) | 0.79 (0.7–0.8)* |
Type of damage | ||||
No damage | 84.2% (76.9–91.4) | 1 | 79.9% (71.6–88.2) | 1 |
Lateral | 70.8% (64.9–76.8) | 0.84 (0.8–0.9)* | 55% (46.3–63.7) | 0.69 (0.6–0.7)* |
Susceptible strain | ||||
Multiple | 85.1% (78.4–91.7) | 1.0 (0.9–1.1) | 74.3% (64.0–84.5) | 0.93 (0.9–1.0) |
Central | 72.1% (55.2–89.1) | 0.86 (0.8–0.9)* | 65.4% (48.7–82.0) | 0.82 (0.7–0.9)* |
RR = rate ratio, estimated with Poisson regression models. CI = confidence interval.
*P < 0.001.
&P = 0.052.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.